Fifth Third Bancorp »

Kymera Therapeutics shares owned by Fifth Third Bancorp

Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by Fifth Third Bancorp from 13F filings

Historical chart of Fifth Third Bancorp investment in Kymera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kymera Therapeutics held by Fifth Third Bancorp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kymera Therapeutics by Fifth Third Bancorp

Quarter filed Position value Share count Share price at filing
2026-03-31 $4.3M 51k 83.29

More positions owned by Fifth Third Bancorp

NVIDIA Corporation (NVDA)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Eli Lilly & Co. (LLY)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Ishares Tr S&p 100 Etf (OEF)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Exxon Mobil Corporation (XOM)
Ishares Tr Core S&p Mcp Etf (IJH)

View all positions for Fifth Third Bancorp

Top funds holding Kymera Therapeutics

FMR
Baker Bros. Advisors
venBio Select Advisor
Vanguard Group
BVF
BlackRock
Atlas Venture Life Science Advisors
Wellington Management Company
Siren
Vanguard Capital Management
Vanguard Portfolio Management
State Street Corporation
Capital Research Global Investors
Geode Capital Management
Driehaus Capital Management

View all funds holding Kymera Therapeutics